Understanding VDDR2: Why Total Hair Loss Accompanies Severe Vitamin D Receptor Blocks

Vitamin D dependent rickets type 2 (VDDR2) alopecia is a rare genetic disorder that combines the classic features of rickets with total hair loss. It results from mutations in the vitamin D receptor (VDR) gene, making tissues resistant to the active form of vitamin D (1,25-dihydroxyvitamin D). Below, we explain the biology, symptoms, diagnosis, and management of VDDR2 alopecia, clarifying why receptor blocks lead to both bone disease and total hair loss.

What Is Vitamin D Dependent Rickets Type 2 (VDDR2)?

• VDDR2 is an autosomal recessive disorder caused by mutations in the VDR gene.
• The VDR normally binds 1,25-dihydroxyvitamin D (calcitriol), regulating calcium and phosphate balance.
• In VDDR2, mutated VDR cannot activate target genes, leading to poor calcium absorption in the gut and impaired bone mineralization (rickets).
• A hallmark of VDDR2 is alopecia—ranging from patchy hair loss to total scalp and body hair loss.

How VDR Mutations Lead to Rickets

1. Calcium and Phosphate Imbalance

   • Active vitamin D increases intestinal absorption of calcium and phosphate.
   • Without functional VDR, calcium levels drop (hypocalcemia), phosphate levels may be low, and parathyroid hormone (PTH) rises.
   • Chronic hypocalcemia weakens bones, causing rickets in children and osteomalacia in adults.

2. Bone Deformities and Symptoms

   • Bowed legs, chest wall deformities (“rachitic rosary”), delayed growth, and muscle weakness.
   • Severe cases can have life-threatening complications such as hypocalcemic seizures.

Why Alopecia Occurs in VDDR2

• VDR in Hair Follicles

• The VDR is expressed in keratinocytes and dermal papilla fibroblasts within hair follicles.
• It regulates genes critical for the hair cycle, especially the transition from the resting phase (telogen) to the growth phase (anagen).

• Cellular Differentiation and Cycling

• VDR controls signaling pathways (e.g., Wnt/β-catenin) that drive hair follicle stem cell activation.
• When VDR is nonfunctional, these pathways falter, leading to failure of hair follicle regeneration after each cycle.

• Resulting Hair Loss

• Early in life, affected infants may have normal lanugo hair that falls out within months.
• Over time, they develop total scalp and body alopecia (both vellus and terminal hair).
• Unlike nutritional deficiencies, hair does not regrow even with high-dose vitamin D supplements.

Clinical Presentation

Patients with VDDR2 alopecia typically present in infancy or early childhood:

• Skeletal Signs

• Delayed fontanelle closure
• Craniotabes (soft skull bones)
• Rachitic deformities of the long bones
• Waddling gait as they begin to walk

• Laboratory Findings

• Elevated 1,25-dihydroxyvitamin D (calcitriol) levels – a compensatory rise
• Low to normal calcium, low phosphate
• Elevated PTH
• Alkaline phosphatase often elevated

• Dermatologic Features

• Scalp alopecia progressing to total hair loss
• Sparse or absent eyebrows and eyelashes
• Fine vellus hairs may be present but fall out

Diagnosis

1. Clinical History and Exam

   • Rickets unresponsive to conventional vitamin D
   • Early-onset alopecia

2. Laboratory Tests

   • Measure serum calcium, phosphate, PTH, alkaline phosphatase, and 1,25-dihydroxyvitamin D.

3. Genetic Testing

   • Sequencing of the VDR gene confirms pathogenic mutations.

4. Skin or Scalp Biopsy (Rarely Needed)

   • Histology shows absence of anagen (growth phase) hair follicles.

Treatment and Management

While there is no cure for VDDR2 alopecia, management focuses on correcting metabolic imbalances and preventing complications:

• High-Dose Calcitriol or Other Active Vitamin D Analogues

• Doses often exceed 1.5 mcg/kg/day of calcitriol.
• May partially correct calcium levels in some patients with milder VDR mutations.

• High-Dose Oral Calcium or Intravenous Calcium

• Oral calcium supplements up to 2–3 g/day elemental calcium.
• IV calcium infusions in refractory cases or during life-threatening hypocalcemia.

• Monitoring and Supportive Care

• Regular growth assessments, bone X-rays, and blood tests.
• Orthopedic interventions for severe bone deformities.
• Nutritional support to ensure adequate growth.

• Hair Loss

• Unfortunately, hair rarely regrows because the underlying receptor defect persists.
• Cosmetic options (wigs, scarves) and psychosocial support.

Prognosis

• Early diagnosis and aggressive management of calcium levels can prevent seizures, promote better bone health, and support growth.
• Rickets may improve, but alopecia typically remains permanent.
• Lifelong follow-up with a multidisciplinary team (endocrinologist, orthopedist, dermatologist) is essential.

When to Seek Help

If you or your child has unexplained bone pain, visible bone deformities, delayed growth, or hair loss, consider taking a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/). It can guide you on whether to see a specialist. For anything potentially life-threatening or serious, always speak to a doctor promptly.

Key Takeaways

• Vitamin D dependent rickets type 2 alopecia arises from VDR gene mutations, causing resistance to active vitamin D.
• Classic features include rickets unresponsive to vitamin D and total hair loss due to failed hair follicle cycling.
• Diagnosis relies on clinical signs, lab tests, and genetic confirmation.
• Management centers on high-dose calcitriol or calcium therapy; alopecia usually persists.
• Early intervention improves bone outcomes; psychosocial support is vital for hair loss.

If you suspect symptoms of VDDR2 or have concerns about rickets or unexplained hair loss, speak to a doctor to explore testing and treatment options.